Other factors including the expression of glucose transporter (GluT1, GluT4) and disturbance of the intestinal microbiome might imply elevated blood glucose, as observed in preclinical animal models and patients on depression (49–51). Here, SLC2A1 is linked to depressive symptom measurement.